Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

Cancer Cell. 2021 Aug 9;39(8):1042-1044. doi: 10.1016/j.ccell.2021.06.019. Epub 2021 Jul 1.

¹ Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
² Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
³ Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁴ Division of Population Science, Dana-Farber Cancer Institute and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁵ Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: qtrinh@bwh.harvard.edu.
⁶ Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address: toni_choueiri@dfci.harvard.edu.

No abstract available

Publication types